天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
Chinese English Japanese Germany Korea
010-86108875
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Ecteinascidin 770
114899-80-8

Ecteinascidin 770 synthesis

15synthesis methods
Ethanamine, N-[(3,5-dichlorophenyl)methylene]-2,2-diethoxy-

1000210-73-0
0 suppliers
inquiry

Ethanamine, N-[(3,5-dichlorophenyl)methylene]-2,2-diethoxy-

1000210-73-0
0 suppliers
inquiry

Ecteinascidin 770

114899-80-8
44 suppliers
inquiry

-

Yield: 33.4% , 27.8%

Reaction Conditions:

Stage #1:triallyl-ecteinascidin 770 with bis-triphenylphosphine-palladium(II) chloride;tri-n-butyl-tin hydride;acetic acid in tetrahydrofuran at 25; for 6 h;
Stage #2: with sodium hydrogencarbonate in tetrahydrofuran;water

Steps:

5.1.2. Deallylation of 4c: 2'-N-allyl Et 770 4d
Tributyltin hydride (0.16 mL, 0.61 mmol) was added dropwise over 10 min to a vigorously stirred solution of 4c (32.9 mg, 37.0 μmol), (Ph3P)2PdCl2 (15.6 mg, 22.2 μmol), and AcOH (79.4 μL, 1.39 mmol) in THF (10 mL) at 25 °C, and the mixture was stirred for 6 h at 25 °C. The mixture was diluted with water (10 mL), made alkaline with 5% aqueous NaHCO3, and extracted with chloroform (30 mL × 3). The combined extracts were washed with 5% aqueous NaHCO3, dried, and concentrated in vacuo to give a residue. Chromatography on a silica gel column with hexane-ethyl acetate (5:1) to gave 1b (9.5 mg, 33.4%) as a colorless solid, whose spectral data were in complete agreement with those of the authentic sample. Further elution with hexane-ethyl acetate (2:1) afforded 2'-N-Allyl Et 770 (4d: 8.3 mg, 27.8%). [α]D22 -80.1 (c 0.25, CHCl3); IR (KBr) 3447br, 2930, 2250w, 1749, 1508, 1458, 1375, 1234, 1196, 1161, 1107, 1086, 1005, 914 cm-1; 1H NMR (CDCl3, 500 MHz) δ 6.47 (1H, s, 15-H), 6.45 (1H, s, 5'-H), 6.22 (1H, s, 8'-H), 6.08 (1H, d, J = 1.2 Hz, OCHO), 5.97 (1H, d, J = 1.2 Hz, OCHO), 5.69 (1H, s, 18-OH), 5.57 (1H, ddt, J = 17.0, 10.2, 6.3 Hz, NCH2CHCH2), 5.42 (1H, br s, 6'-OH), 5.11 (1H, dd, J = 17.0, 1.7 Hz, NCH2CHCH2), 5.02 (1H, dd, J = 10.2, 1.7 Hz, NCH2CHCH2), 4.96 (1H, d, J = 11.4 Hz, 22-H), 4.62 (1H, br s, 4-H), 4.37 (1H, d, J = 2.3 Hz, 1-H), 4.26 (1H, dd, J = 5.1, 1.2 Hz, 11-H), 4.11 (1H, d, J = 2.9 Hz, 21-H), 3.91 (1H, dd, J = 11.4, 2.9 Hz, 22-H), 3.76 (3H, s, 17-OCH3), 3.56 (3H, s, 7'-OCH3), 3.53 (1H, d, J = 5.1 Hz, 3-H), 3.42 (1H, br d, J = 9.0 Hz, 13-H), 3.08 (2H, br d, NCH2CH), 2.95 (1H, dd, J = 17.0, 9.1 Hz, 14-Hα), 2.94 (1H, m. 3'-H), 2.80 (1H, d, J = 17.0 Hz, 14-Hβ), 2.74 (1H, dt, J = 12.5, 4.5 Hz, 3'-H), 2.56 (1H, ddd, J = 15.8, 10.2, 5.1 Hz, 4'-H), 2.56 (1H, br, 12'-H), 2.49 (1H, m, 12'-H), 2.34 (1H, dt, J = 15.8, 3.9 Hz, 4'-H), 2.30 (3H, s, OCOCH3), 2.25 (3H, s, 16-CH3), 2.11 (3H, s, NCH3), 2.03 (3H, s, 6-CH3); 13C NMR (CDCl3, 125 MHz) δ 169.6 (1'-CO), 168.4 (5-OCO), 147.3 (C-18), 145.5 (C-7), 144.5 (C-6'), 144.1 (C-7'), 142.9 (C-17), 141.8 (C-5), 140.6 (C-8), 138.1 (NCH2CHCH2), 130.7 (C-20), 130.2 (C-10'), 129.4 (C-16), 127.4 (C-9'), 121.6 (C-10), 121.2 (C-15), 118.4 (C-19), 118.3 (21-CN), 115.4 (NCH2CHCH2), 114.5 (C-9), 113.9 (C-5'), 112.5 (C-6), 110.9 (C-8'), 102.0 (OCH2O), 71.1 (C-1'), 61.1 (C-3), 60.7 (C-22), 60.4 (C-1), 60.1 (17-OCH3), 60.0 (C-21), 55.4 (7'-OCH3), 54.9 (C-11), 54.7 (C-13), 54.2 (NCH2CH), 43.7 (C-3'), 43.0 (C-4), 41.8 (NCH3), 39.7(C-12'), 27.8 (C-4'), 24.9 (C-14), 20.3 (COCH3), 16.1 (16-CH3), 9.7 (6-CH3); FABMS m/z 811 (MH+); HRFABMS m/z 811.3011 (MH+, calcd for C43H47N4O10S, 811.3013), CD Δε nm (c 12.3 μM, methanol, 32 °C) -29.4 (210), -66.7 (218), 0 (244), 9.6 (253), 0 (270), -13.8 (286), 0 (320).

References:

Saktrakulkla, Panithi;Toriumi, Satoru;Tsujimoto, Mitsuhiro;Patarapanich, Chamnan;Suwanborirux, Khanit;Saito, Naoki [Bioorganic and Medicinal Chemistry,2011,vol. 19,# 15,p. 4421 - 4436] Location in patent:experimental part